171 related articles for article (PubMed ID: 25907250)
1. Differential effects of antipsychotic drugs on insight in first episode schizophrenia: Data from the European First-Episode Schizophrenia Trial (EUFEST).
Pijnenborg GH; Timmerman ME; Derks EM; Fleischhacker WW; Kahn RS; Aleman A
Eur Neuropsychopharmacol; 2015 Jun; 25(6):808-16. PubMed ID: 25907250
[TBL] [Abstract][Full Text] [Related]
2. Efficacy of antipsychotic drugs against hostility in the European First-Episode Schizophrenia Trial (EUFEST).
Volavka J; Czobor P; Derks EM; Bitter I; Libiger J; Kahn RS; Fleischhacker WW;
J Clin Psychiatry; 2011 Jul; 72(7):955-61. PubMed ID: 21824456
[TBL] [Abstract][Full Text] [Related]
3. Effectiveness of antipsychotics in first-episode schizophrenia and schizophreniform disorder on response and remission: an open randomized clinical trial (EUFEST).
Boter H; Peuskens J; Libiger J; Fleischhacker WW; Davidson M; Galderisi S; Kahn RS;
Schizophr Res; 2009 Dec; 115(2-3):97-103. PubMed ID: 19819114
[TBL] [Abstract][Full Text] [Related]
4. Extrapyramidal symptoms during treatment of first schizophrenia episode: results from EUFEST.
Rybakowski JK; Vansteelandt K; Remlinger-Molenda A; Fleischhacker WW; Kahn RS; Peuskens J;
Eur Neuropsychopharmacol; 2014 Sep; 24(9):1500-5. PubMed ID: 25085534
[TBL] [Abstract][Full Text] [Related]
5. Treatment of depression in first episode of schizophrenia: results from EUFEST.
Rybakowski JK; Vansteelandt K; Szafranski T; Thys E; Jarema M; Wolfgang Fleischhacker W; Kahn RS; Peuskens J;
Eur Neuropsychopharmacol; 2012 Dec; 22(12):875-82. PubMed ID: 22627166
[TBL] [Abstract][Full Text] [Related]
6. Cognitive effects of antipsychotic drugs in first-episode schizophrenia and schizophreniform disorder: a randomized, open-label clinical trial (EUFEST).
Davidson M; Galderisi S; Weiser M; Werbeloff N; Fleischhacker WW; Keefe RS; Boter H; Keet IP; Prelipceanu D; Rybakowski JK; Libiger J; Hummer M; Dollfus S; López-Ibor JJ; Hranov LG; Gaebel W; Peuskens J; Lindefors N; Riecher-Rössler A; Kahn RS
Am J Psychiatry; 2009 Jun; 166(6):675-82. PubMed ID: 19369319
[TBL] [Abstract][Full Text] [Related]
7. Gender differences in the treatment of first-episode schizophrenia: Results from the European First Episode Schizophrenia Trial.
Ceskova E; Prikryl R; Libiger J; Svancara J; Jarkovsky J
Schizophr Res; 2015 Dec; 169(1-3):303-307. PubMed ID: 26545298
[TBL] [Abstract][Full Text] [Related]
8. The European First Episode Schizophrenia Trial (EUFEST): rationale and design of the trial.
Fleischhacker WW; Keet IP; Kahn RS;
Schizophr Res; 2005 Oct; 78(2-3):147-56. PubMed ID: 16055308
[TBL] [Abstract][Full Text] [Related]
9. Effectiveness of antipsychotic drugs in first-episode schizophrenia and schizophreniform disorder: an open randomised clinical trial.
Kahn RS; Fleischhacker WW; Boter H; Davidson M; Vergouwe Y; Keet IP; Gheorghe MD; Rybakowski JK; Galderisi S; Libiger J; Hummer M; Dollfus S; López-Ibor JJ; Hranov LG; Gaebel W; Peuskens J; Lindefors N; Riecher-Rössler A; Grobbee DE;
Lancet; 2008 Mar; 371(9618):1085-97. PubMed ID: 18374841
[TBL] [Abstract][Full Text] [Related]
10. Metabolic risk factors in first-episode schizophrenia: baseline prevalence and course analysed from the European First-Episode Schizophrenia Trial.
Fleischhacker WW; Siu CO; Bodén R; Pappadopulos E; Karayal ON; Kahn RS;
Int J Neuropsychopharmacol; 2013 Jun; 16(5):987-95. PubMed ID: 23253821
[TBL] [Abstract][Full Text] [Related]
11. Efficacy of iloperidone in the short-term treatment of schizophrenia: a post hoc analysis of pooled patient data from four phase III, placebo- and active-controlled trials.
Citrome L; Meng X; Hochfeld M; Stahl SM
Hum Psychopharmacol; 2012 Jan; 27(1):24-32. PubMed ID: 22161738
[TBL] [Abstract][Full Text] [Related]
12. Oral versus injectable antipsychotic treatment in early psychosis: post hoc comparison of two studies.
Emsley R; Oosthuizen P; Koen L; Niehaus DJ; Medori R; Rabinowitz J
Clin Ther; 2008 Dec; 30(12):2378-86. PubMed ID: 19167596
[TBL] [Abstract][Full Text] [Related]
13. Effects of antipsychotics on insight in schizophrenia: results from independent samples of first-episode and acutely relapsed patients.
Misiak B; Frydecka D; Beszłej JA; Moustafa AA; Tybura P; Kucharska-Mazur J; Samochowiec A; Bieńkowski P; Samochowiec J
Int Clin Psychopharmacol; 2016 Jul; 31(4):185-91. PubMed ID: 26836264
[TBL] [Abstract][Full Text] [Related]
14. What do large scale studies of medication in schizophrenia add to our management strategies?
Agius M; Davis A; Gilhooley M; Chapman S; Zaman R
Psychiatr Danub; 2010 Jun; 22(2):323-8. PubMed ID: 20562774
[TBL] [Abstract][Full Text] [Related]
15. The impact of second generation antipsychotics on insight in schizophrenia: Results from 14 randomized, placebo controlled trials.
Mattila T; Koeter M; Wohlfarth T; Storosum J; van den Brink W; Derks E; Leufkens H; Denys D
Eur Neuropsychopharmacol; 2017 Jan; 27(1):82-86. PubMed ID: 27842941
[TBL] [Abstract][Full Text] [Related]
16. Interpreting treatment trials in schizophrenia patients: lessons learned from EUFEST.
Fleischhacker WW; Derks E; Kahn RS
Schizophr Res; 2012 Jun; 138(1):39-40. PubMed ID: 22542244
[TBL] [Abstract][Full Text] [Related]
17. Efficacy and safety of ziprasidone in the treatment of first-episode psychosis: an 8-week, open-label, multicenter trial.
Zhao T; Park TW; Yang JC; Huang GB; Kim MG; Lee KH; Chung YC
Int Clin Psychopharmacol; 2012 Jul; 27(4):184-90. PubMed ID: 22426471
[TBL] [Abstract][Full Text] [Related]
18. Changes in insight over the first 24 months of treatment in schizophrenia spectrum disorders.
Phahladira L; Asmal L; Kilian S; Chiliza B; Scheffler F; Luckhoff HK; du Plessis S; Emsley R
Schizophr Res; 2019 Apr; 206():394-399. PubMed ID: 30385130
[TBL] [Abstract][Full Text] [Related]
19. Randomized controlled trial of effect of prescription of clozapine versus other second-generation antipsychotic drugs in resistant schizophrenia.
Lewis SW; Barnes TR; Davies L; Murray RM; Dunn G; Hayhurst KP; Markwick A; Lloyd H; Jones PB
Schizophr Bull; 2006 Oct; 32(4):715-23. PubMed ID: 16540702
[TBL] [Abstract][Full Text] [Related]
20. The nature and evolution of insight in schizophrenia: a multi-informant longitudinal study of first-episode versus chronic patients.
Koren D; Viksman P; Giuliano AJ; Seidman LJ
Schizophr Res; 2013 Dec; 151(1-3):245-51. PubMed ID: 24189291
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
